Additionally, AIM2 deficiency in B cells modulates B-cell differentiation through the Blimp-1-Bcl-6 axis, leading to the amelioration of systemic lupus erythematosus (SLE) (42). This evidence concerns the gene PRDM1 and systemic lupus erythematosus.